Advertisement
Screener

Mirum Pharmaceuticals, Inc. (MIRM) Pre-Tax Margin

Mirum Pharmaceuticals, Inc. (MIRM) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin -37.19%.
  • 2026-03-31: Pre-Tax Margin -493.91%.
  • 2025-12-31: Pre-Tax Margin -3.33%.
  • 2025-09-30: Pre-Tax Margin 1.99%.

Complete source-backed pre-tax margin history.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-30-37.19%
2026-03-31-493.91%
2025-12-31-3.33%
2025-09-301.99%
2025-06-30-4.27%
2025-03-31-12.23%
2024-12-31-24.51%
2024-09-30-15.37%
2024-06-30-30.82%
2024-03-31-35.62%
2023-12-31-50.94%
2023-09-30-48.90%
2023-06-30-196.61%
2023-03-31-94.72%
2022-12-31-130.05%
2022-09-30-190.06%
2022-06-30-191.56%
2022-03-31-283.86%
2021-12-311834.23%
2021-09-30-941.98%
2021-06-30-398.94%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-4.11%
2024-12-31-25.80%
2023-12-31-87.15%
2022-12-31-184.36%
2021-12-31-438.66%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Liquidia Corp (LQDA)United States$6.347B51.23
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Veradermics, Inc (MANE)United States$4.839B